4.7 Review

Trends in US Cardiovascular Care 2016 Report From 4 ACC National Cardiovascular Data Registries

期刊

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 69, 期 11, 页码 1427-1450

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2016.12.005

关键词

acute coronary syndromes; congenital heart disease; implantable cardioverter-defibrillators; percutaneous coronary intervention; quality of care

资金

  1. Roche Diagnostics
  2. Abbott Diagnostics
  3. Medtronic
  4. St. Jude Medical
  5. American College of Cardiology
  6. Centers for Medicaid & Medicare Services
  7. Eli Lilly
  8. Sanofi
  9. Daiichi-Sankyo
  10. Janssen Pharmaceuticals
  11. Ferring Pharmaceuticals
  12. Myokardia
  13. AstraZeneca
  14. American Heart Association
  15. Familial Hypercholesterolemia Foundation
  16. PriMed
  17. Boehringer Ingelheim
  18. Merck
  19. Actelion
  20. Amgen
  21. Novartis
  22. Quest Diagnostics
  23. Elsevier Publishers
  24. Gilead
  25. Lilly
  26. Abbott Vascular

向作者/读者索取更多资源

Cardiovascular disease is a leading cause of death and disability in the United States. National programs, such as the National Cardiovascular Data Registry, facilitate assessments of the quality of care and outcomes for broad populations of patients with cardiovascular disease. This report provides data for 2014 from 4 National Cardiovascular Data Registry hospital quality programs: 1) CathPCI (Diagnostic Catheterization and Percutaneous Coronary Intervention) for coronary angiography and percutaneous coronary intervention (667,424 procedures performed in 1,612 hospitals); 2) ICD Registry for implantable cardioverter-defibrillators (158,649 procedures performed in 1,715 hospitals); 3) ACTION-GWTG (Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines) for acute coronary syndromes (182,903 patients admitted to 907 hospitals); and 4) IMPACT (Improving Pediatric and Adult Congenital Treatment) for cardiac catheterization and intervention for pediatric and adult congenital heart disease (20,169 procedures in 76 hospitals). The report provides perspectives on the demographic and clinical characteristics of enrolled patients, characteristics of participating centers, and selected measures of processes and outcomes of care in these programs. (J Am Coll Cardiol 2017; 69: 1427-50) (C) 2017 by the American College of Cardiology Foundation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据